Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ...
The European Patent Office last week upheld one of Moderna’s key patents, handing the biotech an important victory in its ...
Moderna has received its second drug approval from US regulators for an RSV vaccine in older adults, a step forward in the biotech’s efforts to convince investors of its path back to growth after the ...
The US District Court of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer in damages for infringing patents related ...
Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing ...
The Cambridge biotech said Friday that the European Patent Office has upheld the validity of one of its key patents, a ...
USA-based Moderna has won a case at the European Patent Office (EPO) in its dispute with Pfizer and BioNTech over its Covid-19 vaccine, in a boost for the mRNA-vaccine maker in its ongoing legal fight ...
Covid-19 sub-variants, nicknamed "FLiRT", have been the dominant forms of the virus circulating this year globally, according ...
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the ...
Then $75 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial.
Moderna said that the European Patent Office had decided to maintain the validity of one of the company's key patents ...
London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and ...